Description
Global Markets Direct ' s latest Pharmaceutical and Healthcare disease pipeline guide Presbyopia – Pipeline Review, H2 2016, provides an overview of the Presbyopia( Ophthalmology) pipeline landscape.
Presbyopia is an eye condition in which eye slowly loses the ability to focus quickly on objects that are close. Presbyopia happens in people as they age. Signs and symptoms include headaches, eyestrain, difficulty reading small print and fatigue. Risk factors include anemia, diabetes, cardiovascular disease, hyperopia, multiple sclerosis, myasthenia gravis and eye trauma.
Request a sample of this report @ http:// orbisresearch. com / contacts / request-sample / 171250.
Report Highlights Global Markets Direct ' s Pharmaceutical and Healthcare latest pipeline guide Presbyopia – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Presbyopia( Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action( MoA), route of administration( RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Purchase a copy of this report @ http:// orbisresearch. com / contact / purchase / 171250. For more information contact sales @ orbisresearch. com
The Presbyopia( Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Presbyopia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies / Universities / Institutes, the molecules developed by Companies in Phase II, Preclinical and Discovery stages are 5, 1 and 1 respectively.
Presbyopia( Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’ s proprietary databases, company / university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company / university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Browse Complete Report @ http:// orbisresearch. com / reports / index / presbyopia-pipeline-review-h2- 2016.
Some points from TOC:
Table of Contents Table of Contents 2 www. orbisresearch. com; + 1( 214) 884-6817; + 9120-64101019